Evidence-based value of subcutaneous surgical wound drainage: the largest systematic review and meta-analysis.

Published

Journal Article (Review)

BACKGROUND: The purpose of this study was to determine the evidenced-based value of prophylactic drainage of subcutaneous wounds in surgery. METHODS: An electronic search was performed. Articles comparing subcutaneous prophylactic drainage with no drainage were identified and classified by level of evidence. If sufficient randomized controlled trials were included, a meta-analysis was performed using the random-effects model. Fifty-two randomized controlled trials were included in the meta-analysis, and subgroups were determined by specific surgical procedures or characteristics (cesarean delivery, abdominal wound, breast reduction, breast biopsy, femoral wound, axillary lymph node dissection, hip and knee arthroplasty, obesity, and clean-contaminated wound). Studies were compared for the following endpoints: hematoma, wound healing issues, seroma, abscess, and infection. RESULTS: Fifty-two studies with a total of 6930 operations were identified as suitable for this analysis. There were 3495 operations in the drain group and 3435 in the no-drain group. Prophylactic subcutaneous drainage offered a statistically significant advantage only for (1) prevention of hematomas in breast biopsy procedures and (2) prevention of seromas in axillary node dissections. In all other procedures studied, drainage did not offer an advantage. CONCLUSIONS: Many surgical operations can be performed safely without prophylactic drainage. Surgeons can consider omitting drains after cesarean section, breast reduction, abdominal wounds, femoral wounds, and hip and knee joint replacement. Furthermore, surgeons should consider not placing drains prophylactically in obese patients. However, drain placement following a surgical procedure is the surgeon's choice and can be based on multiple factors beyond the type of procedure being performed or the patient's body habitus. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, II.

Full Text

Duke Authors

Cited Authors

  • Kosins, AM; Scholz, T; Cetinkaya, M; Evans, GRD

Published Date

  • August 2013

Published In

Volume / Issue

  • 132 / 2

Start / End Page

  • 443 - 450

PubMed ID

  • 23584625

Pubmed Central ID

  • 23584625

Electronic International Standard Serial Number (EISSN)

  • 1529-4242

International Standard Serial Number (ISSN)

  • 0032-1052

Digital Object Identifier (DOI)

  • 10.1097/prs.0b013e3182958945

Language

  • eng